| Project/Area Number |
25861520
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Otorhinolaryngology
|
|---|
| Research Institution | Asahikawa Medical College |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
|---|
| Keywords | 鼻性NK/T細胞リンパ腫 / Epstein-Barr virus / microRNA / ebv-miR-BART22 / 頭頸部外科学 / 悪性リンパ腫 / 悪性腫瘍 |
|---|
| Outline of Final Research Achievements |
Nasal natural killer/T cell lymphoma (NNKTL) is Epstein-Barr virus (EBV)-associated malignancy and characterized by a poor prognosis. In the present study, microarray analysis showed that ebv-miR-BART22 was highly expressed in NNKL cell lines. We found that ebv-miR-BART22 could regulate PCDC4 expression. Moreover, we showed that knockdown of ebv-miR-BAR22 induced apoptosis in NNKTL cells. These data suggest that ebv-miR-BART22 implicates in cell proliferation regulating PDCD4 expression in NNKTL.
|
